Crunchbase News

FEBRUARY 19, 2025

billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. The smash hit of the past year was Tempus AI , an artificial intelligence precision medicine company that went public in June.

Healthcare 115

Healthcare Artificial Inteligence Biotech Artificial Intelligence 115

Crunchbase News

DECEMBER 5, 2024

While some things tend to slow as the year winds down, artificial intelligence fundraising apparently isn’t one of them. xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a round valuing it at $50 billion, The Wall Street Journal reported. Let’s take a look. billion in 2021.

Artificial Inteligence 127

Artificial Inteligence Artificial Intelligence Generative AI Biotech 127

Crunchbase News

NOVEMBER 12, 2024

Writer’s platform is designed to help businesses use large language models to improve workflows and offers AI solutions that can execute complex enterprise operations across systems and teams. Existing investors Accenture , Balderton Capital , Insight Partners and Vanguard also participated.

Artificial Inteligence 124

Artificial Inteligence Artificial Intelligence Retail Generative AI 124

CIO

MARCH 4, 2025

Artificial intelligence: Driving ROI across the board AI is the poster child of deep tech making a direct impact on business performance. Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products.

Technology 177

Technology Biotech Artificial Inteligence Artificial Intelligence 177

Crunchbase News

NOVEMBER 7, 2024

The surge was driven by large funds leading supergiant rounds in capital-intensive businesses in areas such as artificial intelligence, data centers and energy. The second-largest sector, healthcare and biotech, raised around $5.6 OpenAI raised the largest round last month, a $6.6

Data Center 131

Data Center Energy Biotech Data 131

N2Growth Blog

OCTOBER 23, 2023

Understanding the Unique Challenges in Recruiting for Biotech and Life Sciences The recruitment process in the biotech and life sciences industry comes with its own set of unique challenges. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

Crunchbase News

NOVEMBER 1, 2024

OpenAI , $6.6B, artificial intelligence: OpenAI announced its long-awaited raise of $6.6 tied) Poolside , $500M, artificial intelligence: Poolside closed a $500 million Series B led by Bain Capital Ventures. The startup builds artificial intelligence software for programmers. billion, per Crunchbase.

Biotech 123

Biotech Energy Artificial Inteligence Artificial Intelligence 123

Crunchbase News

JANUARY 23, 2025

However, that is nothing new for the firm when it comes to large AI investments in the U.S. It was reported MGX a $100 billion artificial intelligence-focused investment vehicle founded by sovereign wealth fund Mubadala and Abu Dhabi-based AI company G42 plans to contribute about $7 billion to the new Stargate Project.

Artificial Inteligence 112

Artificial Inteligence Technical Review Artificial Intelligence Biotech 112

TechCrunch

DECEMBER 16, 2022

6 investors discuss why AI is more than just a buzzword in biotech. In her latest investor survey, Anna Heim spoke to six biotech investors about where AI creates value, short-term market shifts, and how they’d like to be approached by founders: Robert Mittendorff, M.D, general partner and head of healthcare, B Capital.

Case Study 215

Case Study Biotech Survey Study 215

Crunchbase News

FEBRUARY 4, 2025

Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. tied) Anthropic , $1B, artificial intelligence: Anthropic, a ChatGPT rival with its AI assistant Claude, is reportedly taking in a fresh $1 billion investment from previous investor Google.

Biotech 125

Biotech Artificial Inteligence Artificial Intelligence Technical Review 125

Crunchbase News

DECEMBER 9, 2024

Biotech offerings, while more plentiful, are also running well below prior highs. Below, we pick out winners and losers for venture-backed tech and biotech companies, focusing on large- and medium-sized IPOs. Top biotech performers Biotech companies that debuted on public markets this year also saw plenty of ups and downs.

Biotech 123

Biotech Film Performance Marketing 123

Crunchbase News

NOVEMBER 22, 2024

To a great degree, the largest rounds of the year went to a handful of AI companies working on large language models and underlying technologies to scale them. While the Boston startup scene is famous for biotech and deeptech talent, the city has lagged other hubs in creation of ultra-high-valuation AI unicorns.

Technical Review 134

Technical Review Artificial Inteligence Biotech Energy 134

TechCrunch

FEBRUARY 11, 2021

Just three years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. “I hope it doesn’t sound corny, but we don’t have the luxury to move more slowly,” explained Immunai co-founder and CEO Noam Solomon in an interview.

Artificial Inteligence 305

Artificial Inteligence Machine Learning Biotech Chemicals 305

Ooda Loop

DECEMBER 23, 2024

It was winner-takes-all in biotech investing in 2024. In late April San Francisco-based artificial intelligence drug discovery start-up Xaira announced it had raised $1bn in one […] The post Why bigger is not always better in biotech appeared first on OODAloop.

Biotech 59

Biotech Artificial Inteligence Artificial Intelligence Company 59

Crunchbase News

FEBRUARY 18, 2025

artificial intelligence. ” Marketing AI AI has had a profound effect on many sectors like biotech and cybersecurity, as many startups have added the technology to their platforms. Founded in 2018, the company has raised $172 million, per Crunchbase. It’s a reimagining of the job of being a marketer.”

Marketing 119

Marketing Artificial Inteligence Artificial Intelligence Biotech 119

Crunchbase News

JANUARY 7, 2025

Table of Contents Breakout year for AI Q4 push Large values, billion-dollar rounds US gained, Silicon Valley fired up Late-stage Q4 boom Early stage flat Seed settled Liquidity hold-up Methodology Glossary of funding terms Related reading Breakout year for AI One thing was clear: 2024 was the breakout year for funding to AI companies.

Artificial Inteligence 144

Artificial Inteligence Artificial Intelligence Report Technical Review 144

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. The third advance involves machine learning to accelerate the process of turning optical data (the CD-style scanning signal) into usable data.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

Crunchbase News

NOVEMBER 22, 2024

Just as the holiday season begins, a sleighful of companies unveiled large funding rounds. xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. The $6 billion round valued the company at $24 billion post money.

Artificial Inteligence 122

Artificial Inteligence Artificial Intelligence Biotech Generative AI 122

TechCrunch

NOVEMBER 16, 2022

AI and proteins have been in the news lately, but largely because of the efforts of research outfits like DeepMind and Baker Lab. Their machine learning models take in easily collected RNA sequence data and predict the structure a protein will take — a step that used to take weeks and expensive special equipment.

Generative AI 206

Generative AI Artificial Inteligence Biotech Machine Learning 206

TechCrunch

MARCH 17, 2023

Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The

Budget 230

Budget Biotech Artificial Inteligence Banking 230

Crunchbase News

JUNE 21, 2024

Biotech/healthcare and cybersecurity dominated the run of big rounds this week, with a few AI startups also seeing good-sized checks. Marea Therapeutics , $190M, biotech: This big biotech round is actually the combination of two rounds. The top five raises this week came from sectors that have seen good heat recently.

Biotech 115

Biotech Artificial Inteligence Artificial Intelligence Healthcare 115

TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.”

Biotech 211

Biotech Artificial Inteligence Artificial Intelligence Pharmaceuticals 211

Ooda Loop

MARCH 4, 2025

After a rocky two years, money has started flowing back to biotech, with the return of the megaround exemplified in the $1 billion fundraise of 2024s top moneymaker, Xaira Therapeutics. Few biotechs can expect to collect $1 billion in financing in one fell swoop, but the artificial-intelligence-focused company did just that.

Biotech 59

Biotech Artificial Inteligence Artificial Intelligence Company 59

TechCrunch

OCTOBER 3, 2022

The software Form Bio developed is meant to bring a suite of workflow solutions to the computational biology space, which uses data and modeling to understand biological systems and includes sectors like gene therapy and biotech.

Biotech 240

Biotech Software Machine Learning Artificial Inteligence 240

Crunchbase News

MARCH 8, 2024

However, this week it was clearly biotech leading the way, with three startups from the sector nabbing spots in the top five. Alumis , $259M, biotech: This week saw the biggest biotech raise of the year thus far. While this was the biggest biotech raise of the week, it is by no means the only one on this list.

Biotech 120

Biotech Pharmaceuticals Systems Review Artificial Inteligence 120

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. 2021 should be a banner year for biotech startups that make smart choices early. Engine does so with a pair of tools it has dubbed NetMAPPR and CombiGEM.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.

Biotech 122

Biotech Artificial Inteligence Artificial Intelligence Hotels 122

Crunchbase News

APRIL 2, 2024

Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.

Biotech 117

Biotech Generative AI Automotive Machine Learning 117

Crunchbase News

FEBRUARY 28, 2025

After a couple of blistering weeks, large funding rounds slowed down to a crawl, with only two rounds hitting nine figures. Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year.

Biotech 78

Biotech Artificial Inteligence Artificial Intelligence Healthcare 78

TechCrunch

SEPTEMBER 13, 2022

French biotech company WhiteLab Genomics has raised $10 million in funding for an AI platform designed to aid the discovery and development of genomic therapies. “We provide customers with exhaustive predictive models combining genetics and computational biology in order to design and select the top candidates to be tested in the lab.”

Biotech 258

Biotech Development Pharmaceuticals Machine Learning 258

Crunchbase News

MAY 24, 2024

Nevertheless, the week saw a $1 billion round go to yet another AI startup, and biotech and blockchain also saw some big deals. Scale AI , $1B, artificial intelligence: This week was like many — one topped with a big AI round. It was a slower week for big rounds compared to many of the past few.

Artificial Inteligence 122

Artificial Inteligence Biotech Artificial Intelligence Healthcare 122

TechCrunch

MAY 20, 2022

With cloud-based servers and sophisticated, yet inexpensive, sensors both on the body and off, patients can be monitored at home more effectively than in a hospital, especially when the sensor data is analyzed with artificial intelligence (AI) and machine-learning technology. Opportunities for digital biomarkers.

Artificial Inteligence 231

Artificial Inteligence Artificial Intelligence Healthcare Technical Review 231

TechCrunch

JUNE 1, 2021

Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. The company leverages machine learning and a large body of knowledge about chemical reactions to create these processes, though as CSO Stanis?aw odarczyk-Pruszy?ski

Chemicals 246

Chemicals Artificial Inteligence Off-The-Shelf Machine Learning 246

Crunchbase News

JUNE 4, 2024

xAI , $6B, artificial intelligence: Elon Musk ’s generative AI startup, xAI , officially announced its long-awaited fundraise — making it the second-most-valuable generative AI company in the world behind only competitor OpenAI. It introduced its latest AI model, called Grok-1.5, earlier this year.

Artificial Inteligence 126

Artificial Inteligence Biotech Artificial Intelligence Generative AI 126

Crunchbase News

JANUARY 9, 2025

In 2023, it partnered with Digital Realty to develop $7 billion in data centers targeting providers of online content, cloud services and artificial intelligence. Last year it was reported the worlds largest asset manager plans to invest $8.2 billion to develop data centers in Spain.

Storage 124

Storage Data Center Artificial Inteligence Artificial Intelligence 124

Crunchbase News

JUNE 28, 2024

Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. EvolutionaryScale , $142M, biotech: It was a big week for biotech. billion, per Crunchbase.

Artificial Inteligence 116

Artificial Inteligence Biotech Generative AI Healthcare 116